Portfolio News VahatiCor Guest User 5/18/26 VahatiCor Guest User 5/18/26 VahatiCor Appoints Harry D. Rowland, Ph.D., as Chief Executive Officer Read More VahatiCor Kathryn Deebel 11/18/25 VahatiCor Kathryn Deebel 11/18/25 VahatiCor Closes Oversubscribed Series B Financing to Accelerate A-FLUX® Development for Coronary Microvascular Dysfunction. Read More
VahatiCor Guest User 5/18/26 VahatiCor Guest User 5/18/26 VahatiCor Appoints Harry D. Rowland, Ph.D., as Chief Executive Officer Read More
VahatiCor Kathryn Deebel 11/18/25 VahatiCor Kathryn Deebel 11/18/25 VahatiCor Closes Oversubscribed Series B Financing to Accelerate A-FLUX® Development for Coronary Microvascular Dysfunction. Read More
